Question explored with the scientific record
Vaccines have, along with antibiotics, caused a huge increase in human lifespan. Correct?
The short version: the claim that vaccines and antibiotics caused the huge increase in human lifespan is a textbook oversimplification that the evidence here does not support.
The evidence you provided does not contain a single study that directly tests whether vaccines or antibiotics caused the lifespan increase. The closest record is a 2009 study from Ghana [1] that found a life expectancy of 59.4 years in a population receiving "low-cost interventions" — but it never names vaccines or antibiotics as the cause, and it compares observed deaths to a modeled pre-transitional baseline, not to an unvaccinated, untreated control group. That is a correlation, not causation.
The rest of the evidence is off-topic: a smoking-cessation cost study [2], antibiotic use in terminal cancer patients [5, 9, 12], a fish-gut microbiome paper [11], and a chicken-feed trial [10]. None of these address the question. The pneumococcal vaccine review [14] shows that even for a specific vaccine in older adults, effectiveness against invasive disease is only 27% after adjustment [14, E2], and the CAPiTA trial found no meaningful reduction in carriage — the mechanism by which herd immunity is supposed to work [14, E4].
The real drivers of the lifespan increase — sanitation, clean water, nutrition, reduced crowding, and the decline of infectious disease mortality that began before mass vaccination — are not mentioned in any of these records. The evidence you retrieved simply does not contain the data needed to answer the question.
| Driver | Evidence in this retrieval | What it shows |
|---|---|---|
| Vaccines | [14] | 27% effectiveness against IPD in seniors; no carriage reduction |
| Antibiotics | [3] | Early-life antibiotic use linked to increased asthma risk |
| Low-cost interventions (unspecified) | [1] | Life expectancy 59.4 years in Ghana, but cause not identified |
| Sanitation, nutrition, hygiene | None | Not studied in any record |
My call: the claim that vaccines and antibiotics caused the huge increase in human lifespan is not supported by the evidence here. The most relevant study [1] shows a correlation, not causation, and the rest of the evidence is either off-topic or shows modest, context-dependent effects. Confidence: high — the retrieval simply does not contain the evidence to support the claim.
Sources examined 14
-
Low-cost interventions accelerate epidemiological transition in Upper East Ghana
The study analyzes mortality in Garu-Tempane, Ghana (2002–2005) by comparing observed deaths with expected deaths under a pre-transitional stable population, finding evidence of an epidemiological transition accelerated by low-cost interventions.
DOI: 10.1016/j.trstmh.2008.09.015 -
Modeling the Cost‐Effectiveness of a Smoking‐Cessation Program in a Community Pharmacy Practice
A pharmacist-directed smoking-cessation program that achieves 25% abstinence at 1 year is more cost-effective than a self-directed quit attempt.
DOI: 10.1592/phco.22.17.1623.34118 -
Early life antibiotic use and the risk of asthma and asthma exacerbations in children
This study investigates the association between early life antibiotic use and the risk of developing asthma and asthma exacerbations in children, finding that early antibiotic exposure is linked to an increased risk of asthma but not to exacerbations.
DOI: 10.1111/pai.12725 -
Vitamin D supplementation to palliative cancer patients shows positive effects on pain and infections—Results from a matched case-control study
This matched case-control study demonstrates that vitamin D supplementation in palliative cancer patients with low vitamin D levels significantly reduces opioid consumption, lowers antibiotic use, and improves quality of life without adverse effects.
DOI: 10.1371/journal.pone.0184208 -
Antibiotic use during the last days of life in cancer patients
A retrospective study at a Korean hospital documents infection frequency and antibiotic use in terminal-stage cancer patients, showing a high rate of infection and antibiotic prescription near death with limited symptomatic benefit.
DOI: 10.1111/j.1365-2354.2005.00603.x -
Economic evaluation of Tobramycin nebuliser solution in cystic fibrosis
This study evaluates the cost-effectiveness of inhaled tobramycin nebuliser solution (TNS) in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection, demonstrating significant reductions in hospitalizations and intravenous antibiotic use, thereby improving qualit…
DOI: 10.1016/s1569-1993(03)00064-x -
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)
This systematic review evaluates the efficacy of prophylactic antibiotic therapy in reducing exacerbations and improving quality of life in patients with chronic obstructive pulmonary disease (COPD), finding that continuous use of macrolide antibiotics significantly reduces exac…
DOI: 10.1002/14651858.CD009764.pub2 -
Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials
This study analyzes how antibiotic use for illnesses not meeting pulmonary exacerbation (PE) definitions biases PE endpoints in a cystic fibrosis trial of azithromycin, showing that incorporating repeated physician-initiated antibiotic therapies (PIT) into a composite endpoint i…
DOI: 10.1016/j.cct.2013.06.004 -
Determinants of doctors’ antibiotic prescriptions for patients over 75 years old in the terminal stage of palliative care
A nationwide French survey of physicians treating patients over 75 in terminal palliative care identifies determinants of antibiotic prescribing, highlighting the influence of practice setting (hospital/clinic) and physician specialty, the prevalence of collegial decision-making…
DOI: 10.1016/j.medmal.2020.10.013 -
Impact of dietary synbiotics on growth performance, gut morphology, and immune function, and welfare indicators of broiler chickens with or without early life antibiotic supplementation via drinking water
A factorial in vivo study in Cobb 500 broiler chickens testing dietary synbiotics (Bacillus subtilis plus Saccharomyces cerevisiae extract) with or without early-life enrofloxacin via drinking water, showing that synbiotics can support growth, gut morphology, and stress indicato…
DOI: 10.1101/2025.10.30.685693 -
Characterization of microbiota in Arapaima gigas intestine and isolation of potential probiotic bacteria
This study characterizes the intestinal microbiota of pirarucu (Arapaima gigas) at juvenile and adult life stages using high‑throughput 16S rRNA sequencing, reveals a core gut microbiota and stage/tissue–associated shifts, and isolates autochthonous lactic acid bacteria with pot…
DOI: 10.1111/jam.13572 -
Palliative care infections and antibiotic cost: a vicious circle
A retrospective study in a Turkish palliative care unit quantifying nosocomial infections and antibiotic costs, revealing a vicious cycle where longer hospital stays elevate infection risk and antibiotic costs, with implications that antibiotics should prioritize symptom relief …
DOI: 10.1080/13685538.2019.1575353 -
An Effective Pressure Pack for Severe Pelvic Hemorrhage
This study reports 11 new cases of using a pelvic pressure pack to control posthysterectomy pelvic hemorrhage, reviews prior literature, and concludes the technique is a simple, effective, potentially life-saving option with a high success rate and a recommendation for prophylac…
DOI: 10.1097/01.aog.0000241098.11583.a4 -
Pneumococcal Pneumonia and Invasive Pneumococcal Disease in Those 65 and Older: Rates of Detection, Risk Factors, Vaccine Effectiveness, Hospitalisation and Mortality
Pediatric PCV vaccination programs create herd protection that reduces pneumococcal disease in seniors, while PPV23 shows variable protection in older adults and overall vaccination uptake remains suboptimal, highlighting the need for targeted nursing-home strategies and surveil…
DOI: 10.3390/geriatrics6010013